{"transactions":[{"id":1423170,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-26T17:33:29.000Z","date":"2024-08-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":19624,"price":1.52,"value":29828.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Upon the consummation of the Merger, pursuant to the Merger Agreement, 19,624 shares of Common Stock were converted into the right to receive the Merger Consideration, for an aggregate of $29,828, equal to the product of (x) the Merger Consideration, multiplied by (y) the total number of shares of Common Stock owned by the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-24-092937","document":"tm2422466-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465924092937/tm2422466-3_4seq1.xml","form_type":"4"}},{"id":1423169,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-26T17:33:29.000Z","date":"2024-08-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":28125,"price":1.52,"value":42750.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Upon the consummation of the merger (the \"Merger\") pursuant to that certain Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of June 25, 2024, by and among Agile Therapeutics, Inc. (the \"Company\"), Insud Pharma, S.L. (\"Insud\"), and Exeltis Project, Inc., a Delaware corporation and indirect, wholly owned subsidiary of Insud (\"Merger Sub\"), 28,125 restricted stock units (\"Agile RSUs\") were cancelled and converted into the right to receive a cash payment of $1.52 (the \"Merger Consideration\") per Agile RSU, for an aggregate of $42,750, equal to the product of (x) the Merger Consideration, multiplied by (y) the total number of shares of Common Stock subject to such Agile RSU owned by the reporting person."}],"balance_after":19624,"source":{"system":"sec-edgar","filing":"0001104659-24-092937","document":"tm2422466-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465924092937/tm2422466-3_4seq1.xml","form_type":"4"}},{"id":1516299,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-15T20:14:44.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":13162,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs have a one year cliff vesting period, provided that the director (a) remains a member of the Board of Directors of the issuer on such vesting date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU was granted on May 13, 2024 for no consideration."}],"balance_after":69495,"source":{"system":"sec-edgar","filing":"0001628280-24-023555","document":"wk-form4_1715804068.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000162828024023555/wk-form4_1715804068.xml","form_type":"4"}},{"id":1840959,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-06-30T16:37:43.000Z","date":"2023-06-28","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on June 28, 2023. 25% of the shares subject to the stock option vest on June 28, 2024, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on June 28, 2027."}],"balance_after":12500,"derivative":{"exercise_price":2.48,"expiration_date":"2033-06-27","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001104659-23-077176","document":"tm2320328-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465923077176/tm2320328-3_4seq1.xml","form_type":"4"}},{"id":1840958,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-30T16:37:43.000Z","date":"2023-06-28","kind":"grant","planned":false,"acquired":true,"shares":8963,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares represent RSUs that were granted on June 28, 2023, which will vest and be settled in common stock on June 28, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On April 10, 2023, the Issuer completed a one-for-fifty reverse stock split of the Issuer's common stock. This amount has been adjusted to give effect to this reverse stock split."}],"balance_after":47749,"source":{"system":"sec-edgar","filing":"0001104659-23-077176","document":"tm2320328-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465923077176/tm2320328-3_4seq1.xml","form_type":"4"}},{"id":1840957,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-30T16:37:43.000Z","date":"2023-06-28","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") which were granted on June 28, 2023. The RSUs will vest in four equal installments over four years upon the anniversary of the grant, such that the RSUs will be fully vested on June 28, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On April 10, 2023, the Issuer completed a one-for-fifty reverse stock split of the Issuer's common stock. This amount has been adjusted to give effect to this reverse stock split."}],"balance_after":38786,"source":{"system":"sec-edgar","filing":"0001104659-23-077176","document":"tm2320328-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465923077176/tm2320328-3_4seq1.xml","form_type":"4"}},{"id":1893836,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-15T20:19:46.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":13192,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was granted on May 11, 2023, for no consideration."}],"balance_after":56333,"source":{"system":"sec-edgar","filing":"0001628280-23-018193","document":"wf-form4_168418195780663.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000162828023018193/wf-form4_168418195780663.xml","form_type":"4"}},{"id":2117699,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-11-14T16:34:58.000Z","date":"2022-11-09","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on November 9, 2022. 25% of the shares subject to the stock option vest on November 9, 2023, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on November 9, 2026."}],"balance_after":30000,"derivative":{"exercise_price":0.2,"expiration_date":"2032-11-08","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-22-118636","document":"tm2230300-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465922118636/tm2230300-3_4seq1.xml","form_type":"4"}},{"id":2171615,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-08-29T08:30:25.000Z","date":"2022-08-26","kind":"purchase","acquired":true,"shares":50000,"price":0.45,"value":22500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.4467 to $0.4498, inclusive. The reporting person undertakes to provide to Agile Therapeutics, Inc., any security holder of Agile Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":64343,"source":{"system":"sec-edgar","filing":"0001104659-22-095384","document":"tm2224680-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465922095384/tm2224680-1_4seq1.xml","form_type":"4"}},{"id":2272392,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-13T22:17:23.000Z","date":"2022-05-11","kind":"grant","acquired":true,"shares":14645,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was granted on May 11, 2022, for no consideration."}],"balance_after":43141,"source":{"system":"sec-edgar","filing":"0001140361-22-019185","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000114036122019185/form4.xml","form_type":"4"}},{"id":2430209,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-01-20T21:32:07.000Z","date":"2022-01-19","kind":"grant","acquired":true,"shares":675000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 19, 2022. 25% of the shares subject to the stock option vest on January 19, 2023, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on January 19, 2026."}],"balance_after":675000,"derivative":{"exercise_price":0.342,"expiration_date":"2032-01-18","underlying":"Common Stock","underlying_shares":675000},"source":{"system":"sec-edgar","filing":"0001104659-22-006130","document":"tm224102-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465922006130/tm224102-3_4seq1.xml","form_type":"4"}},{"id":2542294,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrants (right to buy)","published_at":"2021-10-14T08:00:20.000Z","date":"2021-10-13","kind":"purchase","acquired":true,"shares":29412,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person purchased the reported securities at a combined public offering price of $0.85 per one share of common stock together with one-half of a warrant to purchase one share of common stock."}],"balance_after":29412,"derivative":{"exercise_price":0.85,"exercise_date":"2021-10-13","expiration_date":"2026-10-13","underlying":"Common Stock","underlying_shares":29412},"source":{"system":"sec-edgar","filing":"0001104659-21-126012","document":"tm2129958-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465921126012/tm2129958-1_4seq1.xml","form_type":"4"}},{"id":2542293,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-14T08:00:20.000Z","date":"2021-10-13","kind":"purchase","acquired":true,"shares":58824,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person purchased the reported securities at a combined public offering price of $0.85 per one share of common stock together with one-half of a warrant to purchase one share of common stock."}],"balance_after":573734,"source":{"system":"sec-edgar","filing":"0001104659-21-126012","document":"tm2129958-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465921126012/tm2129958-1_4seq1.xml","form_type":"4"}},{"id":2622050,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-07-29T19:52:49.000Z","date":"2021-07-29","kind":"purchase","acquired":true,"shares":26200,"price":1.2632,"value":33095.84,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $1.26 to $1.3299, inclusive. The reporting person undertakes to provide to Agile Therapeutics, Inc., any security holder of Agile Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":514910,"source":{"system":"sec-edgar","filing":"0001104659-21-097783","document":"tm2123597d2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465921097783/tm2123597d2_4seq1.xml","form_type":"4"}},{"id":2705168,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-05-19T08:30:20.000Z","date":"2021-05-18","kind":"purchase","acquired":true,"shares":20000,"price":1.61,"value":32200.0,"ownership":{"direct":true},"balance_after":488710,"source":{"system":"sec-edgar","filing":"0001104659-21-069099","document":"tm2116049-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465921069099/tm2116049-2_4seq1.xml","form_type":"4"}},{"id":2712668,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-14T20:21:28.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":7558,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was granted on May 12, 2021, for no consideration."}],"balance_after":28496,"source":{"system":"sec-edgar","filing":"0001140361-21-017413","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000114036121017413/form4.xml","form_type":"4"}},{"id":2752832,"issuer":{"id":109081,"kind":"organization","name":"Baudax Bio, Inc.","symbol":"BXRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-08T19:03:08.000Z","date":"2021-04-07","kind":"grant","acquired":true,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on April 7, 2022."}],"balance_after":83333,"derivative":{"exercise_price":1.24,"expiration_date":"2031-04-07","underlying":"Common Stock","underlying_shares":83333},"source":{"system":"sec-edgar","filing":"0001192482-21-000326","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000119248221000326/edgar.xml","form_type":"4"}},{"id":2752831,"issuer":{"id":109081,"kind":"organization","name":"Baudax Bio, Inc.","symbol":"BXRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-08T19:03:08.000Z","date":"2021-04-07","kind":"grant","acquired":true,"shares":56452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All shares of common stock are represented by unvested restricted stock units that will vest on April 7, 2022. Vested shares will be delivered to the reporting person within 30 days following the vesting date."}],"balance_after":117785,"source":{"system":"sec-edgar","filing":"0001192482-21-000326","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000119248221000326/edgar.xml","form_type":"4"}},{"id":2774500,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-03-23T17:24:28.000Z","date":"2021-03-23","kind":"purchase","acquired":true,"shares":12500,"price":2.0024,"value":25030.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $1.9950 to $2.0050, inclusive. The reporting person undertakes to provide to Agile Therapeutics, Inc., any security holder of Agile Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":468710,"source":{"system":"sec-edgar","filing":"0001104659-21-040396","document":"tm2110667-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465921040396/tm2110667-1_4seq1.xml","form_type":"4"}},{"id":2892013,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-01-28T18:37:13.000Z","date":"2021-01-27","kind":"grant","acquired":true,"shares":692641,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 27, 2021. 25% of the shares subject to the stock option vest on January 27, 2022, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on January 27, 2025."}],"balance_after":692641,"derivative":{"exercise_price":2.82,"expiration_date":"2031-01-26","underlying":"Common Stock","underlying_shares":692641},"source":{"system":"sec-edgar","filing":"0001104659-21-008906","document":"tm214338d1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465921008906/tm214338d1_4seq1.xml","form_type":"4"}},{"id":2952087,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-09T21:09:22.000Z","date":"2020-12-07","kind":"sale","acquired":false,"shares":20000,"price":39.57,"value":791400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This is the weighted average sales price representing 20,000 shares sold at prices ranging from $39.01 to $40.14 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request."}],"balance_after":20938,"source":{"system":"sec-edgar","filing":"0001104659-20-133640","document":"tm2036583-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000110465920133640/tm2036583-3_4seq1.xml","form_type":"4"}},{"id":2967802,"issuer":{"id":109081,"kind":"organization","name":"Baudax Bio, Inc.","symbol":"BXRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-24T16:08:55.000Z","date":"2020-11-23","kind":"purchase","acquired":true,"shares":5000,"price":1.0599,"value":5299.5,"ownership":{"direct":true},"balance_after":61333,"source":{"system":"sec-edgar","filing":"0001192482-20-000795","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000119248220000795/edgar.xml","form_type":"4"}},{"id":3050906,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-08-20T16:15:43.000Z","date":"2020-08-20","kind":"exercise","acquired":false,"shares":94599,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on December 9, 2010 and is currently fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.76,"expiration_date":"2020-12-08","underlying":"Common Stock","underlying_shares":94599},"source":{"system":"sec-edgar","filing":"0001104659-20-097236","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465920097236/a4.xml","form_type":"4"}},{"id":3050905,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-08-20T16:15:43.000Z","date":"2020-08-20","kind":"exercise","acquired":true,"shares":94599,"price":1.76,"value":166494.24,"ownership":{"direct":true},"balance_after":456210,"source":{"system":"sec-edgar","filing":"0001104659-20-097236","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465920097236/a4.xml","form_type":"4"}},{"id":3101796,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-06-23T17:00:24.000Z","date":"2020-06-22","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on December 9, 2010 and is currently fully vested and exercisable."}],"balance_after":94599,"derivative":{"exercise_price":1.76,"expiration_date":"2020-12-08","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-20-076109","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465920076109/a4.xml","form_type":"4"}},{"id":3101795,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-06-23T17:00:24.000Z","date":"2020-06-22","kind":"exercise","acquired":true,"shares":50000,"price":1.76,"value":88000.0,"ownership":{"direct":true},"balance_after":361611,"source":{"system":"sec-edgar","filing":"0001104659-20-076109","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465920076109/a4.xml","form_type":"4"}},{"id":3149267,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-15T00:58:31.000Z","date":"2020-05-12","kind":"grant","acquired":true,"shares":8097,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was granted on May 12, 2020 for no consideration."}],"balance_after":40938,"source":{"system":"sec-edgar","filing":"0001104659-20-061853","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000110465920061853/a4.xml","form_type":"4"}},{"id":3156193,"issuer":{"id":109081,"kind":"organization","name":"Baudax Bio, Inc.","symbol":"BXRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-08T20:18:00.000Z","date":"2020-05-06","kind":"grant","acquired":true,"shares":34574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on May 6, 2021."}],"balance_after":34574,"derivative":{"exercise_price":3.05,"expiration_date":"2030-05-06","underlying":"Common Stock","underlying_shares":34574},"source":{"system":"sec-edgar","filing":"0001192482-20-000332","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000119248220000332/edgar.xml","form_type":"4"}},{"id":3156192,"issuer":{"id":109081,"kind":"organization","name":"Baudax Bio, Inc.","symbol":"BXRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-08T20:18:00.000Z","date":"2020-05-06","kind":"grant","acquired":true,"shares":22951,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All shares of common stock are represented by unvested restricted stock units that will vest on May 6, 2021. Vested shares will be delivered to the reporting person within 30 days following the vesting date."}],"balance_after":56333,"source":{"system":"sec-edgar","filing":"0001192482-20-000332","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000119248220000332/edgar.xml","form_type":"4"}},{"id":3193027,"issuer":{"id":109081,"kind":"organization","name":"Baudax Bio, Inc.","symbol":"BXRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-27T15:51:37.000Z","date":"2020-03-26","kind":"purchase","acquired":true,"shares":5000,"price":2.34,"value":11700.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price of $2.3442. The range of prices for the sale of these shares was $2.3300 - $2.3500 rounded to the nearest ten-thousandths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":33382,"source":{"system":"sec-edgar","filing":"0001192482-20-000259","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000119248220000259/edgar.xml","form_type":"4"}},{"id":3243602,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-02-27T21:27:51.000Z","date":"2020-02-27","kind":"exercise","acquired":false,"shares":16541,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.71,"exercise_date":"2010-03-18","expiration_date":"2020-03-18","underlying":"Common Stock","underlying_shares":16541},"source":{"system":"sec-edgar","filing":"0001104659-20-026463","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465920026463/a4.xml","form_type":"4"}},{"id":3243601,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-02-27T21:27:51.000Z","date":"2020-02-27","kind":"purchase","acquired":true,"shares":10000,"price":2.71,"value":27100.0,"ownership":{"direct":true},"balance_after":311611,"source":{"system":"sec-edgar","filing":"0001104659-20-026463","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465920026463/a4.xml","form_type":"4"}},{"id":3243600,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-02-27T21:27:51.000Z","date":"2020-02-27","kind":"exercise","acquired":true,"shares":16541,"price":0.71,"value":11744.11,"ownership":{"direct":true},"balance_after":301611,"source":{"system":"sec-edgar","filing":"0001104659-20-026463","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465920026463/a4.xml","form_type":"4"}},{"id":3302771,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-01-24T19:59:37.000Z","date":"2020-01-22","kind":"grant","acquired":true,"shares":833333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 22, 2020.  25% of the shares subject to the stock option vest on January 22, 2021, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on January 22, 2024."}],"balance_after":833333,"derivative":{"exercise_price":2.83,"expiration_date":"2030-01-21","underlying":"Common Stock","underlying_shares":833333},"source":{"system":"sec-edgar","filing":"0001104659-20-006858","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465920006858/a4.xml","form_type":"4"}},{"id":3302770,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-01-24T19:59:37.000Z","date":"2020-01-22","kind":"grant","acquired":true,"shares":26502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units which were granted on January 22, 2020, and which will vest and be settled in common stock on January 22, 2021."}],"balance_after":285070,"source":{"system":"sec-edgar","filing":"0001104659-20-006858","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465920006858/a4.xml","form_type":"4"}},{"id":3347953,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-09T18:37:38.000Z","date":"2019-12-05","kind":"grant","acquired":true,"shares":15284,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units will vest in full on the earlier of (i) a change of control of Recro Pharma, Inc. (the \"Company\") (as defined in the Company's 2018 Amended and Restated Equity Incentive Plan) or (ii) December 5, 2020, subject to continued service with the Company."}],"balance_after":44196,"source":{"system":"sec-edgar","filing":"0001192482-19-000497","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000119248219000497/edgar.xml","form_type":"4"}},{"id":3347951,"issuer":{"id":109081,"kind":"organization","name":"Baudax Bio, Inc.","symbol":"BXRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-09T18:17:00.000Z","date":"2019-12-05","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units are scheduled to vest 50% each on December 5, 2020 and December 5, 2021, subject to continued service through the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total includes common stock acquired pursuant to a special dividend issued on November 21, 2019, whereby all holders of common stock of Recro Pharma, Inc., as of November 15, 2019, received a dividend of one (1) share of Baudax Bio, Inc. common stock for every two and one-half (2.5) shares of Recro Pharma, Inc. common stock."}],"balance_after":28382,"source":{"system":"sec-edgar","filing":"0001192482-19-000474","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000119248219000474/edgar.xml","form_type":"4"}},{"id":3493934,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-06-11T16:30:45.000Z","date":"2019-06-10","kind":"purchase","acquired":true,"shares":20000,"price":1.27,"value":25400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $1.19 to $1.34, inclusive. The reporting person undertakes to provide to Agile Therapeutics, Inc., any security holder of Agile Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":258568,"source":{"system":"sec-edgar","filing":"0001104659-19-034790","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465919034790/a4.xml","form_type":"4"}},{"id":3524224,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-16T21:15:42.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":6899,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the vesting date. Vested shares are delivered within 30 days of vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was granted on May 15, 2019, and represents a contingent right to receive one share of Common Stock."}],"balance_after":32841,"source":{"system":"sec-edgar","filing":"0001127430-19-000073","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743019000073/edgar.xml","form_type":"4"}},{"id":3531312,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-10T16:28:16.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":10888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on May 9, 2020."}],"balance_after":10888,"derivative":{"exercise_price":8.8,"expiration_date":"2029-05-09","underlying":"Common Stock","underlying_shares":10888},"source":{"system":"sec-edgar","filing":"0001192482-19-000249","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000119248219000249/edgar.xml","form_type":"4"}},{"id":3531311,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-10T16:28:16.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":7955,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All shares of common stock are represented by unvested restricted stock units that will vest on May 9, 2020. Vested shares will be delivered to the reporting person within 30 days following the vesting date."}],"balance_after":28912,"source":{"system":"sec-edgar","filing":"0001192482-19-000249","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000119248219000249/edgar.xml","form_type":"4"}},{"id":3571881,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-04-01T17:02:34.000Z","date":"2019-03-25","kind":"purchase","acquired":true,"shares":25000,"price":1.54,"value":38500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $1.51 to $1.55, inclusive. The reporting person undertakes to provide to Agile Therapeutics, Inc., any security holder of Agile Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":238568,"source":{"system":"sec-edgar","filing":"0001104659-19-019002","document":"a4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465919019002/a4a.xml","form_type":"4/A","original_submission_date":"2019-03-26"}},{"id":3578328,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-03-26T17:00:35.000Z","date":"2019-03-25","kind":"purchase","acquired":true,"shares":25000,"price":1.54,"value":38500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $1.51 to $1.55, inclusive. The reporting person undertakes to provide to Agile Therapeutics, Inc., any security holder of Agile Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":238568,"source":{"system":"sec-edgar","filing":"0001104659-19-017469","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465919017469/a4.xml","form_type":"4"}},{"id":3629514,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-27T21:07:33.000Z","date":"2019-02-26","kind":"sale","acquired":false,"shares":5500,"price":30,"value":165000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":25942,"source":{"system":"sec-edgar","filing":"0001127430-19-000040","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743019000040/edgar.xml","form_type":"4"}},{"id":3646597,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-20T21:05:57.000Z","date":"2019-02-15","kind":"sale","acquired":false,"shares":5500,"price":27.5,"value":151250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":31442,"source":{"system":"sec-edgar","filing":"0001127430-19-000032","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743019000032/edgar.xml","form_type":"4"}},{"id":3670682,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-07T21:07:33.000Z","date":"2019-02-05","kind":"sale","acquired":false,"shares":5500,"price":25,"value":137500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":36942,"source":{"system":"sec-edgar","filing":"0001127430-19-000029","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743019000029/edgar.xml","form_type":"4"}},{"id":3681133,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-01-31T17:30:26.000Z","date":"2019-01-29","kind":"grant","acquired":true,"shares":154400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 29, 2019.  25% of the shares subject to the stock option vest on January 29, 2020, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on January 29, 2023."}],"balance_after":154400,"derivative":{"exercise_price":2.5,"expiration_date":"2029-01-28","underlying":"Common Stock","underlying_shares":154400},"source":{"system":"sec-edgar","filing":"0001104659-19-004817","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465919004817/a4.xml","form_type":"4"}},{"id":3681132,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-01-31T17:30:26.000Z","date":"2019-01-29","kind":"grant","acquired":true,"shares":540900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 29, 2019.  25% of the shares subject to the stock option vest on January 29, 2020, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on January 29, 2023."}],"balance_after":540900,"derivative":{"exercise_price":0.84,"expiration_date":"2029-01-28","underlying":"Common Stock","underlying_shares":540900},"source":{"system":"sec-edgar","filing":"0001104659-19-004817","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465919004817/a4.xml","form_type":"4"}},{"id":3685271,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2019-01-28T17:30:35.000Z","date":"2019-01-24","kind":"exercise","acquired":false,"shares":35314,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on January 24, 2018 and were fully vested and delivered on January 24, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on January 24, 2018 and were fully vested and delivered on January 24, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":35314},"source":{"system":"sec-edgar","filing":"0001104659-19-003713","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465919003713/a4.xml","form_type":"4"}},{"id":3685270,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-01-28T17:30:35.000Z","date":"2019-01-24","kind":"exercise","acquired":true,"shares":35314,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":213568,"source":{"system":"sec-edgar","filing":"0001104659-19-003713","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465919003713/a4.xml","form_type":"4"}},{"id":3696618,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-14T21:15:31.000Z","date":"2019-01-10","kind":"sale","acquired":false,"shares":5500,"price":22.5,"value":123750.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":42442,"source":{"system":"sec-edgar","filing":"0001127430-19-000025","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743019000025/edgar.xml","form_type":"4"}},{"id":3885970,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-06-21T17:30:37.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 20, 2018.  25% of the shares subject to the stock option vested on the date of grant. The remaining shares vest in 3 equal 25% installments on December 31, 2018, June 30, 2019 and December 31, 2019."}],"balance_after":150000,"derivative":{"exercise_price":0.58,"expiration_date":"2028-06-19","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-18-041577","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465918041577/a4.xml","form_type":"4"}},{"id":3928747,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-17T20:13:01.000Z","date":"2018-05-15","kind":"grant","acquired":true,"shares":6066,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was granted on May 15, 2018, and represents a contingent right to receive one share of Common Stock."}],"balance_after":47942,"source":{"system":"sec-edgar","filing":"0001127430-18-000037","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743018000037/edgar.xml","form_type":"4"}},{"id":3934546,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-05-14T16:50:37.000Z","date":"2018-05-12","kind":"exercise","acquired":false,"shares":13274,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 12, 2017, the reporting person was granted 13,274 restricted stock units, vesting on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 12, 2017, the reporting person was granted 13,274 restricted stock units, vesting on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":13274},"source":{"system":"sec-edgar","filing":"0001192482-18-000204","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000119248218000204/edgar.xml","form_type":"4"}},{"id":3934545,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-14T16:50:37.000Z","date":"2018-05-12","kind":"exercise","acquired":true,"shares":13274,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":20957,"source":{"system":"sec-edgar","filing":"0001192482-18-000204","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000119248218000204/edgar.xml","form_type":"4"}},{"id":3938676,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-10T18:58:17.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":8965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amended Form 4 is being filed to correct a typographical error in the number of stock options acquired on May 4, 2018 as reported on the Form 4 filed on May 8, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on May 4, 2019."}],"balance_after":8965,"derivative":{"exercise_price":11.32,"expiration_date":"2028-05-04","underlying":"Common Stock","underlying_shares":8965},"source":{"system":"sec-edgar","filing":"0001192482-18-000196","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000119248218000196/edgar.xml","form_type":"4/A","original_submission_date":"2018-05-08"}},{"id":3942371,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-08T17:27:25.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":5742,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on May 4, 2019."}],"balance_after":5742,"derivative":{"exercise_price":11.32,"expiration_date":"2028-05-04","underlying":"Common Stock","underlying_shares":5742},"source":{"system":"sec-edgar","filing":"0001192482-18-000184","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000119248218000184/edgar.xml","form_type":"4"}},{"id":3942370,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-08T17:27:25.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":6183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All shares of common stock are represented by unvested restricted stock units that will vest on May 4, 2019. Vested shares will be delivered to the reporting person within 30 days following the vesting date."}],"balance_after":7683,"source":{"system":"sec-edgar","filing":"0001192482-18-000184","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000119248218000184/edgar.xml","form_type":"4"}},{"id":4068384,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2018-02-09T16:31:19.000Z","date":"2018-02-08","kind":"exercise","acquired":false,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"50,000 restricted stock units were granted on February 8, 2016 and vest as follows: 16,666 units vested and were delivered on the grant date, 16,667 units vested and were delivered on February 8, 2017, and 16,667 units vested and were delivered on February 8, 2018; The 35,314 remaining restricted stock units were granted on January 24, 2018 and will be fully vested and delivered on January 24, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"50,000 restricted stock units were granted on February 8, 2016 and vest as follows: 16,666 units vested and were delivered on the grant date, 16,667 units vested and were delivered on February 8, 2017, and 16,667 units vested and were delivered on February 8, 2018; The 35,314 remaining restricted stock units were granted on January 24, 2018 and will be fully vested and delivered on January 24, 2019."}],"balance_after":35314,"derivative":{"underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001104659-18-008061","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465918008061/a4.xml","form_type":"4"}},{"id":4068383,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-02-09T16:31:19.000Z","date":"2018-02-08","kind":"exercise","acquired":true,"shares":16667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":178254,"source":{"system":"sec-edgar","filing":"0001104659-18-008061","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465918008061/a4.xml","form_type":"4"}},{"id":4088019,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2018-01-26T17:14:54.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":35314,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on January 24, 2018 and will be fully vested and delivered on January 24, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on January 24, 2018 and will be fully vested and delivered on January 24, 2019."}],"balance_after":51981,"derivative":{"underlying":"Common Stock","underlying_shares":35314},"source":{"system":"sec-edgar","filing":"0001104659-18-004312","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465918004312/a4.xml","form_type":"4"}},{"id":4088018,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-01-26T17:14:54.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":256000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 24, 2018.  25% of the shares subject to the stock option vest on January 24, 2019, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on January 24, 2022"}],"balance_after":256000,"derivative":{"exercise_price":3.46,"expiration_date":"2028-01-23","underlying":"Common Stock","underlying_shares":256000},"source":{"system":"sec-edgar","filing":"0001104659-18-004312","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465918004312/a4.xml","form_type":"4"}},{"id":4223417,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & Chief Executive Off"}}],"security":"Common Stock","published_at":"2017-08-28T16:30:37.000Z","date":"2017-08-25","kind":"purchase","acquired":true,"shares":10000,"price":3.34,"value":33400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $3.32 to $3.34, inclusive. The reporting person undertakes to provide to Agile Therapeutics, Inc., any security holder of Agile Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":161587,"source":{"system":"sec-edgar","filing":"0001104659-17-054004","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465917054004/a4.xml","form_type":"4"}},{"id":4312016,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-19T20:28:26.000Z","date":"2017-05-17","kind":"grant","acquired":true,"shares":6702,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was received as a grant on May 17, 2017, and represents a contingent right to receive one share of Common Stock."}],"balance_after":41876,"source":{"system":"sec-edgar","filing":"0001127430-17-000040","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743017000040/edgar.xml","form_type":"4"}},{"id":4318045,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-05-16T16:28:37.000Z","date":"2017-05-12","kind":"grant","acquired":true,"shares":13274,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on May 12, 2018. Vested shares will be delivered to the reporting person within 30 days following the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on May 12, 2018. Vested shares will be delivered to the reporting person within 30 days following the vesting date."}],"balance_after":13274,"derivative":{"underlying":"Common Stock","underlying_shares":13274},"source":{"system":"sec-edgar","filing":"0001123292-17-000940","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000112329217000940/edgar.xml","form_type":"4"}},{"id":4322426,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and Chief Executive O"}}],"security":"Common Stock","published_at":"2017-05-12T07:50:42.000Z","date":"2017-05-11","kind":"purchase","acquired":true,"shares":10000,"price":3.51,"value":35100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $3.34 to $3.59, inclusive. The reporting person undertakes to provide to Agile Therapeutics, Inc., any security holder of Agile Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":151587,"source":{"system":"sec-edgar","filing":"0001104659-17-032097","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465917032097/a4.xml","form_type":"4"}},{"id":4353406,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & Chief Exec Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-04-12T16:32:14.000Z","date":"2017-04-11","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on December 9, 2010 and is currently fully vested and exercisable."}],"balance_after":144599,"derivative":{"exercise_price":1.76,"expiration_date":"2020-12-08","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-17-023100","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465917023100/a4.xml","form_type":"4"}},{"id":4353405,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & Chief Exec Officer"}}],"security":"Common Stock","published_at":"2017-04-12T16:32:14.000Z","date":"2017-04-11","kind":"exercise","acquired":true,"shares":30000,"price":1.76,"value":52800.0,"ownership":{"direct":true},"balance_after":141587,"source":{"system":"sec-edgar","filing":"0001104659-17-023100","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465917023100/a4.xml","form_type":"4"}},{"id":4457008,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2017-02-10T16:32:13.000Z","date":"2017-02-08","kind":"exercise","acquired":false,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"50,000 restricted stock units were granted on February 8, 2016 and vest as follows: 16,666 units vested and were delivered on the grant date, 16,667 units vested and were delivered on February 8, 2017, and 16,667 units will vest and be delivered on February 8, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"50,000 restricted stock units were granted on February 8, 2016 and vest as follows: 16,666 units vested and were delivered on the grant date, 16,667 units vested and were delivered on February 8, 2017, and 16,667 units will vest and be delivered on February 8, 2018."}],"balance_after":16667,"derivative":{"underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001104659-17-008208","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465917008208/a4.xml","form_type":"4"}},{"id":4457007,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-02-10T16:32:13.000Z","date":"2017-02-08","kind":"exercise","acquired":true,"shares":16667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":111587,"source":{"system":"sec-edgar","filing":"0001104659-17-008208","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465917008208/a4.xml","form_type":"4"}},{"id":4479086,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-01-27T16:30:38.000Z","date":"2017-01-25","kind":"grant","acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 25, 2017.  25% of the shares subject to the stock option vest on January 25, 2018, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on January 25, 2021."}],"balance_after":240000,"derivative":{"exercise_price":2.26,"expiration_date":"2027-01-24","underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001104659-17-004561","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000110465917004561/a4.xml","form_type":"4"}},{"id":4518672,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":87999,"kind":"person","name":"ALTOMARI ALFRED","position":1,"cik":"0001285644","reported_name":"ALTOMARI ALFRED","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-16T16:52:53.000Z","date":"2016-12-15","kind":"purchase","acquired":true,"shares":1500,"price":6.55,"value":9825.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.51 to $6.59, inclusive. The reporting person undertakes to provide to Recro Pharma, Inc., any security holder of Recro Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":1500,"source":{"system":"sec-edgar","filing":"0001123292-16-003064","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285644/000112329216003064/edgar.xml","form_type":"4"}}]}